InnoCare Pharma Limited - Current Ratio

The Current Ratio as of June 2026 (TTM) for InnoCare Pharma Limited (INCPF) is 5.65

According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current Current Ratio is 5.65. This represents a change of -11.98% compared to the average of 6.42 of the last 4 quarters.

InnoCare Pharma Limited (INCPF) Historical Current Ratio (quarterly & annually)

How has INCPF Current Ratio performed in the past?

The mean historical Current Ratio of InnoCare Pharma Limited over the last ten years is 16.25. The current 5.65 Current Ratio has changed 3.38% with respect to the historical average. Over the past ten years (40 quarters), INCPF's Current Ratio was at its highest in in the March 2019 quarter at 114.79. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

InnoCare Pharma Limited (INCPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InnoCare Pharma Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InnoCare Pharma Limited (INCPF) Average Current Ratio

How has INCPF Current Ratio performed in the past?

The current Current Ratio of InnoCare Pharma Limited (INCPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

InnoCare Pharma Limited (INCPF) Current Ratio vs. Peers

How is INCPF’s Current Ratio compared to its peers?

InnoCare Pharma Limited’s Current Ratio is greater than Shanghai Junshi Biosciences Co., Ltd. (2.14), greater than Genscript Biotech Corporation (1.47), greater than ALK-Abelló A/S (3.25), greater than Laboratorios Farmaceuticos Rovi, S.A. (3.66), less than Zealand Pharma A/S (37.17), less than Camurus AB (publ) (11.57), greater than COSMOS Pharmaceutical Corporation (0.66), greater than Fielmann AG (1.19), greater than Clicks Group Limited (1.05), greater than Gedeon Richter PLC (4.69),

Build a custom stock screener for InnoCare Pharma Limited (INCPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoCare Pharma Limited (INCPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.